These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24000678)

  • 1. [Programmed approach to the treatment of secondary hyperparathyroidism in chronic renal disease].
    Samokhvalov NA; Maĭstrenko NA; Romashchenko PN
    Vestn Khir Im I I Grek; 2013; 172(2):43-6. PubMed ID: 24000678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis.
    Li W; Zhang S
    Adv Clin Exp Med; 2015; 24(6):1007-12. PubMed ID: 26771973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperparathyroidism in patients on long-term hemodialysis].
    Rodosskaia NK; Orlova II; Brazhnikova VV
    Klin Med (Mosk); 2009; 87(4):68-70. PubMed ID: 19514326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes following "presumed" total parathyroidectomy for secondary hyperparathyroidism of chronic kidney disease.
    Conzo G; Perna A; Candela G; Palazzo A; Parmeggiani D; Napolitano S; Esposito D; Cavallo F; Docimo G; Santini L
    G Chir; 2012; 33(11-12):379-82. PubMed ID: 23140920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S; Wazny LD; Martin JE
    Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid enlargement at dialysis initiation in patients with chronic kidney diseases.
    Nakai K; Fujii H; Kono K; Goto S; Miura S; Maeda A; Takeda K; Nishi S
    Ther Apher Dial; 2013 Feb; 17(1):24-9. PubMed ID: 23379489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Association Between Parathyroid Hormone and Anemia in Hemodialysis Patients.
    Tanaka M; Komaba H; Fukagawa M
    Ther Apher Dial; 2018 Jun; 22(3):242-245. PubMed ID: 29767854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in the therapy of secondary hyperparathyroidism.
    Wood C; González EA; Martin KJ
    Ther Apher Dial; 2005 Feb; 9(1):4-8. PubMed ID: 15828898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.
    Fukagawa M; Komaba H; Onishi Y; Fukuhara S; Akizawa T; Kurokawa K;
    Am J Nephrol; 2011; 33(5):427-37. PubMed ID: 21508631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
    Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
    Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary hyperparathyroidism in chronic renal failure.
    Malmaeus J
    Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
    Kazama JJ
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S44-7. PubMed ID: 17976085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between apelin and parathyroid hormone in hemodialysis patients.
    Mafra D; Lobo JC; Farage NE; Stockler-Pinto MB; Leal VO; Calixto A; Geloneze B
    Ren Fail; 2012; 34(8):970-3. PubMed ID: 22780711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical treatment of secondary hyperparathyroidism in patients with chronic renal failure].
    Hamouda M; Ben Dhia N; Aloui S; Gorsane I; Skhiri H; Frih A; Koobaa J; Driss N; Bouzouita K; Elmay M
    Nephrol Ther; 2011 Apr; 7(2):105-10. PubMed ID: 21112268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysphoria induced in dialysis providers by secondary hyperparathyroidism.
    Soomro IH; Goldfarb DS
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):9-11. PubMed ID: 25516914
    [No Abstract]   [Full Text] [Related]  

  • 16. Diuretics and secondary hyperparathyroidism in chronic kidney disease.
    Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2011 Apr; 26(4):1122-5. PubMed ID: 21460359
    [No Abstract]   [Full Text] [Related]  

  • 17. Paricalcitol in secondary hyperparathyroidism and the survival benefit in patients with chronic kidney disease.
    Al-Baaj F; Yadav P; Al-Rifai A
    J Ren Care; 2011 Jun; 37(2):75-9. PubMed ID: 21561542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
    Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
    Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
    Malluche HH; Ritz E
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary hyperparathyroidism and its sequelae in renal transplant recipients. Long term findings in a series of conservatively managed patients.
    Pieper R; Alveryd A; Lundgren G; Collste H; Magnusson G; Svahn T; Groth CG
    Scand J Urol Nephrol Suppl; 1977; (42):144-8. PubMed ID: 356196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.